Patents by Inventor Luis Alberto Oliveira Dallan

Luis Alberto Oliveira Dallan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9226948
    Abstract: A method of inhibiting postoperative adhesion severity of mammalian tissues. The method includes the application on an operated tissue surface of an effective therapeutic amount of a pharmaceutical composition containing a pharmaceutically acceptable amount of growth factors and sterilized carboxymethylchitosan. A method of inhibiting postoperative adhesion severity that includes the step of applying a composition comprising a growth factor, where the growth factor is used as a modulating factor on mesothelial cell proliferation is also provided.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: January 5, 2016
    Assignees: JACKSON BRANDAO LOPES, LUIS ALBERTO OLIVERIA DALLAN, FUNDACAO SAO FRANCISCO XAVIER
    Inventors: Jackson Brandão Lopes, Luis Alberto Oliveira Dallan
  • Patent number: 8889114
    Abstract: The present invention refers to the use of growth factors, which are effective on mesothelial cell proliferation, used in a sterilized carboxymethylchitosan pharmaceutical composition employed to reduce postoperative adhesions severity. The present invention also provides a method to inhibit postoperative adhesions severity.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: November 18, 2014
    Assignees: Fundacao Sao Francisco Xavier
    Inventors: Jackson Brandão Lopes, Luis Alberto Oliveira Dallan
  • Publication number: 20130217624
    Abstract: A method of inhibiting postoperative adhesion severity of mammalian tissues. The method includes the application on an operated tissue surface of an effective therapeutic amount of a pharmaceutical composition containing a pharmaceutically acceptable amount of growth factors and sterilized carboxymethylchitosan. A method of inhibiting postoperative adhesion severity that includes the step of applying a composition comprising a growth factor, where the growth factor is used as a modulating factor on mesothelial cell proliferation is also provided.
    Type: Application
    Filed: March 18, 2013
    Publication date: August 22, 2013
    Applicant: FUNDAÇÃO SÃO FRANCISCO XAVIER
    Inventors: Fundação São Francisco Xavier, Jackson Brandão Lopes, Luis Alberto Oliveira Dallan
  • Publication number: 20110165095
    Abstract: The present invention refers to the use of growth factors, which are effective on mesothelial cell proliferation, used in a sterilized carboxymethylchitosan pharmaceutical composition employed to reduce postoperative adhesions severity. The present invention also provides a method to inhibit postoperative adhesions severity.
    Type: Application
    Filed: March 19, 2009
    Publication date: July 7, 2011
    Applicant: FUNDACAO SAO FRANCISCO XAVIER
    Inventors: Jackson Brandão Lopes, Luis Alberto Oliveira Dallan